Mylan | 487,166 followers on LinkedIn. Follow us on our new journey as Viatris. | We have combined with Upjohn, a legacy division of Pfizer, and are now Viatris. Founded in 1961 in White Sulphur Springs, West Virginia, Mylan—initially known as “Milan,” named after one of the company’s co-founders, Milan “Mike” Puskar—started with a mission to increase access to high-quality medicine and improve patient health in difficult-to-reach communities. Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing 7 billion people access to high quality medicine. Learn how Mylan grew tremendously from humble beginnings in rural West Virginia to marketing more than 7,500 products worldwide today. Our expertise in coating, laminating, and extrusion of thin films and adhesive laminates led us to be acquired by Mylan and we eventually became part of the Viatris family of companies. Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing 7 billion people access to high quality medicine. At Mylan, delivering better health for a better world isn’t our job. It’s our mission. Look around and see how Mylan is making an impact in your part of the world by increasing access to medicine, investing in scientific research, strengthening communities, and so much more. Mylan is now part of Viatris, a new global healthcare company committed to empowering people to live healthier at every stage of life. We encourage you to learn more about our commitment to increasing access to quality medicines for patients when and where they need them. Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer 's off-patent medicine division, to form Viatris. [2] Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. [2] It is expected that in the coming months, shareholders of Mylan will vote on the proposed combination of Mylan and Upjohn. More information regarding Viatris, including the company’s full executive management team, board of directors, stock symbol, and logo will be available at a later date.